Ongoing concerns about Avandia (rosiglitazone)

April 2010

Ongoing concerns about Avandia (rosiglitazone) will prompt more safety review by FDA....

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Respiratory & Allergy new controversy over treating asthma with long-acting beta-agonists (salmeterol, formoterol)
Men's Health Flomax (tamsulosin) is the first SELECTIVE alpha-blocker for benign prostatic hyperplasia (BPH) to go generic
Respiratory & Allergy whether certain inhalers need to be stored upright
Diabetes whether intensive treatment of blood pressure or lipids is beneficial for type 2 diabetes patients
Neurology & Pain Pennsaid, a new Rx topical diclofenac solution
Pediatrics whether CHILDREN should take fish oil supplements
Gastroenterology Which of these OTCs is NOT like the others...Maalox Advanced, Maalox Total Relief, or Pepto-Bismol
Geriatrics adjust med regimens to help avoid falls in the frail elderly
Statins Stronger warnings about an increased risk of myopathy will limit doses of simvastatin (Zocor, etc)
concerns about the safety of denture adhesives with zinc
whether cell phones, smart phones, and other electronic devices can interfere with hospital equipment
Diabetes Meds Ongoing concerns about Avandia (rosiglitazone)